January 19, 2012
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, proposed to the University of California Regents on Jan. 19 that a small working group be formed to help UCSF explore options to secure its financial future so it can realize its vision to become the world’s preeminent health sciences innovator.
January 17, 2012
Cancers rarely are deadly unless they evolve the ability to grow beyond the tissues in which they first arise.
January 10, 2012
Veterans Affairs hospitals screen elderly men with limited life expectancies for prostate cancer at surprisingly high rates, even though guidelines recommend against such screening, according to a study led by a physician at the UCSF-affiliated San Francisco VA Medical Center (SFVAMC).
January 6, 2012
A new UCSF analysis of tobacco industry documents shows that Philip Morris USA manipulated data on the effects of additives in cigarettes, including menthol, obscuring actual toxicity levels and increasing the risk of heart, cancer and other diseases for smokers.
December 23, 2011
A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired by Japan-based Takeda Pharmaceuticals in an effort to add two novel drug projects to Takeda’s pipeline of potential oncology therapies.
December 22, 2011
Peter Walter, PhD, a professor in the Biochemistry and Biophysics Department within the School of Medicine at the University of California, San Francisco has been awarded the 2012 Paul Ehrlich and Ludwig Darmstaedter Prize for his “outstanding research achievements in the field of cell biology.”